Results 131 to 140 of about 32,595 (294)
One Toke Over the Line: The Proliferation of State Medical Marijuana Laws [PDF]
[Excerpt] “Marijuana has been used for medicinal purposes for at least five thousand years. In fact, it was used medicinally in the United States up until the twentieth century when antidrug zealots managed to prohibit it.
Grandel, Troy E.
core +1 more source
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne +9 more
wiley +1 more source
Alternatives to prohibition illicit drugs: how we can stop killing and criminalising young Australians [PDF]
This report follows from a Roundtable discussion held in July 2012 to consider new approaches to public policy about illicit drugs in Australia. An earlier Australia21 report launched in April 2012 had concluded that attempts to control drug use through ...
Alex Wodak, Bob Douglas, David McDonald
core
A Gateway to Future Problems: Concerns about the State by-State Legalization of Medical Marijuana [PDF]
[Excerpt] “Before 2009, every American presidential administration had been uniform in its policy of consistently enforcing the nation’s drug laws.
Lewis, Paul
core +1 more source
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley +1 more source
From farm to bedside: Potential of medical cannabis in global health
Introduction: The growing opioid crisis and persistent global health disparities underscore the urgent need for alternative therapeutic strategies.
Maureen Bilinga Tendwa +26 more
doaj +1 more source
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure +6 more
wiley +1 more source
Medical Cannabis sativa inflorescence has gained popularity in recent years due to the therapeutic pharmacological characteristics of its components. Cannabis sativa L.-based drugs are effective in treating a variety of illnesses, including constipation,
Sipho Goge +2 more
doaj +1 more source
The Predictive Validity of Marijuana Odor Detection: An Examination of Alaska State Trooper Case Reports 2006–2010 [PDF]
This study provides an empirical estimate of the extent to which Alaska State Troopers (AST) investigators’ detection of marijuana odors served as a reliable indicator of the presence of illegal quantities of marijuana in suspected structures/buildings ...
Brandeis, Jason, Myrstol, Brad A.
core
Varenicline for cannabis use disorder: A randomized controlled trial
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark +8 more
wiley +1 more source

